Kaspi: E-Commerce, Fintech, and Payments Leader in Kazakhstan

January 9, 2022 in Audio, Best Ideas 2022, Equities, Ideas

Javier López Bernardo of BrightGate Capital presented his in-depth investment thesis on Kaspi KZ (UK: KSPI) at Best Ideas 2022.

Thesis summary:

Kaspi KZ is the leading Kazakh e-commerce company, with unassailable positions in fintech and payments processing. The three business lines are inextricably linked through Kaspi’s super app, an ecosystem that enjoys one of the best user engagements in the world and a very high penetration in the total Kazakh population.

Well-run platform businesses are extremely profitable and enjoy high barriers to entry, underpinned by strong network effects and winner-takes-all dynamics.

Kaspi has an undemanding valuation for long-term minded investors. At $119 per share, the company has a market cap of roughly $21 billion and a P/BV multiple of 22x. In light of Kaspi’s ROE of 116%, that implies a 4.8% yield assuming no growth.

Kaspi has still ample growth avenues for the next decade, which together can sustain 13% CAGR, or 16% if the international expansion is successful, with multiples on initial investment ranging between 4x and 5x over a decade.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Javier López Bernardo is currently Portfolio Manager (equities and high yield) at BrightGate Capital SGIIC, an independent asset management boutique company based in Madrid, Spain. He holds a Bachelor in Business Administration (major in finance) by the Universidad Complutense de Madrid, a Master in Corporate Finance and Investment Banking by the IEB and a Master in Economics by Kingston University, where he also earned a Ph.D. in Economics. His academic research on equity markets and growth theory has been published in leading international journals. Additionally, he has been a full-scholarship holder for two years by the Ramón Areces Foundation and he is a CFA charterholder. He is a lecturer for the CFA program and he also regularly delivers lectures in commodities and value investing.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Glass House Brands: Cannabis Company With High Optionality

January 9, 2022 in Audio, Best Ideas 2022, Equities, Ideas

Aaron Edelheit of Mindset Capital presented his investment thesis on Glass House Brands (Canada: GLAS, OTC: GLASF) at Best Ideas 2022.

Thesis summary:

There is a possibility that Glass House, which recently traded at around $4 per share, can earn more than $12 per share in cash flow when its new state of the art greenhouse is fully up and running and if — and yes, this is a big if — interstate commerce is allowed in the cannabis industry.

A caveat: interstate commerce is probably a long way off. As an option, the cash flow numbers are so enormous in an interstate commerce scenario that the upside potential of interstate commerce should be valued at something north of zero. Even if there is a 5% chance of interstate commerce happening, that option alone might be worth $12 per share (20 times $12 per share times 5%).

Even if interstate commerce never happens and if it is only allowed to sell in California, when Glass House gets to scale in its new state of the art greenhouse, it should generate somewhere between $2 and $6 per share in cash flow. This is still a stunning number and could send Glass House up 7 times and possibly more than 20 times from the recent share price.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Aaron M. Edelheit is the CEO and Founder of Mindset Capital, a private investment firm. Aaron also was the Chief Strategy Officer of FLO Technologies, after being one of the first investors in the company, helping the company grow from a pre-revenue startup to raising $28 million and launching in over 500 Home Depot stores. FLO was acquired in January of 2020 by Fortune Brands. In his previous role as CEO of The American Home, Aaron founded and grew a company from 16 rental homes to one that owned 2,500 single family rental homes and was sold in April 2015 to a publicly traded Real Estate Investment Trust. Aaron also founded and ran a successful money management firm, Sabre Value Management from 1998 to 2011. In 2018, IdeaPress published Aaron’s first book, The Hard Break: The Case for a 24/6 Lifestyle. The book makes the case for taking one day off from work, email and smartphones for a more productive, healthier and more creative life. Aaron currently serves on the board of Dignity Moves, which builds cost effective housing for those experiencing homelessness. He has also served on the boards of non-profits such as the Moishe House Foundation and Global Village Project. And he is also a member of Social Venture Partners in Santa Barbara, California. Aaron has also been featured and quoted in the Wall Street Journal, New York Times, Bloomberg, and CNBC among others and has given lectures on business and entrepreneurship in the U.S., Canada and South Africa.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Clorox: Cash-Generative Business With Favorable Long-Term Trends

January 9, 2022 in Audio, Best Ideas 2022, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Bogumil Baranowski of Sicart Associates presented his investment thesis on The Clorox Company (US: CLX) at Best Ideas 2022.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Bogumil Baranowski is a founding partner of Sicart Associates, a New York City based boutique investment firm catering to families and entrepreneurs on both sides of the Atlantic and the Pacific. He has 17 years of investment experience, and holds a Master’s degree in Finance and Strategy from Institut d’Etudes Politiques de Paris (Sciences Po), and a Master’s in Finance and Banking from Warsaw School of Economics. He is the author of Outsmarting the Crowd – A Value Investor’s Guide to Starting, Building and Keeping a Family Fortune (2015), and Money, Life, Family: My Handbook: My complete collection of principles on investing, finding work & life balance, and preserving family wealth (2019). He is a TEDx Speaker, and a former Executive Board member of one of the oldest and most advanced Toastmasters International clubs in New York City, and an Instructor at MOI Global (The Community of Intelligent Investors).

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

ITC Limited: Diversified, Well-Managed Conglomerate in India

January 9, 2022 in Audio, Best Ideas 2022, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Ashish Kila of Perfect Group presented his in-depth investment thesis on ITC Limited (India: ITC) at Best Ideas 2022.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Ashish Kila is a rank holder CA and MBA from MDI Gurgaon. He has worked with leading investment banks like Goldman Sachs & Morgan Stanley in their equity research division and now is the Director at Perfect Group. Ashish looks after the strategic functions of the group and manages the family office fund. Ashish has over the years conducted seminars on value investing, leadership, productivity and startups (angel investing) in prominent institutions like IIM (Calcutta, Indore), ISB (Hyderabad, Mohali), MDI Gurgaon, IBS Gurgaon, SSCBS, DSE, etc; forums like Octoberquest, MOI Global, CFA Society India; institutional firms like Fidelity, BNP Paribas MF, SBI MF, BOI AXA MF, Ambit House. Ashish & his family undertake several social initiatives via the group’s NGO – Perfect Foundation. The family is also actively involved with Bhaorao Deoras Sewa Nyas & is helping manage its two projects, Feeding 2000 people everyday free of cost where >40 lakh people have benefitted & Managing charitable patient attendant facilities across various hospitals in India i.e.~280 bed AIIMS Trauma Delhi, ~250 bed facility IGIMS, Patna , 300 bed near KGMC Lucknow and 800 bed AIIMS Jhajjar.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Centre Testing: Leading Testing and Inspection Provider in China

January 9, 2022 in Audio, Best Ideas 2022, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

James Fletcher of Ethos Investment Management presented his investment thesis on Centre Testing International (China: 300012) at Best Ideas 2022.

Thesis summary:

Centre Testing International (CTI) is the largest player in the testing and inspection services industry in China, which is a structural growth industry growing at 2-3x GDP.

The company is especially strong in the life sciences segment, where it has 8% market share and is 2x bigger than any of their local competitors. TIC market size to GDP in China is 0.35% but growing quickly, and quite underpenetrated still (the global average is 2.5%).

Publicly listed TIC companies have proven to be long-term compounders due to their strong cash generation, wide moats, and structural growth. Global leaders such as SGS, Eurofins, Bureau Veritas, and Intertek are trading at 30x-40x P/E (ttm), with mid- to high-single digit topline growth. On the other hand, CTI can grow the top line at a 20% CAGR for the next five to ten years, and James forecasts that their market share will reach 1.8% from 1.0% in 2020.

CTI’s business model is so robust that since the IPO in 2009 the company has been in a net cash position and has financed M&A projects with internally generated cash. They earn the highest margins and have the strongest return profile in the industry, which they invest back into R&D and the salesforce.

CTI grew revenue by 30% in 2009 (financial crisis), 27%/19% in 2018/19 (US-China trade war), and 12% in 2020 (Covid-19 pandemic).

CTI is privately owned and well-managed compared to their main peers which are state-owned. Mr. Wan Feng, the founder, chairs the board, and Mr. Shentu Xianzhong has been CEO since 2018. He was formerly CEO at SGS China and is a well-regarded CEO in the TIC industry in China.

Trading at 52x 2021E P/E and 2% FCF yield, James forecasts double-digit annualized returns over the next five years and believes this exceptional business is attractive due to the overall sell-off in China.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

James Fletcher is the founder of Ethos Investment Management. He is a portfolio manager with nearly two decades of equity research experience. Prior to starting Ethos Investment Management in 2021, James was Director and Senior Portfolio Manager of the EM SMIDcap fund at APG Asset Management where he oversaw $1 billion AUM through a concentrated, high-conviction approach. James earned a B.S. in Finance from Brigham Young University, where he graduated summa cum laude and with University Honors. He is a CFA charterholder. He is also the founder of Young Investors Society (www.yis.org), a non-profit organization that teaches financial literacy and investing concepts to over 8k high school students across the world.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Telsys: Global Leader in Growing Niche Market With High Margins

January 9, 2022 in Audio, Best Ideas 2022, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Omri Velvart of Legacy Value Partners presented his in-depth investment thesis on Telsys Ltd. (Israel: TLSY) at Best Ideas 2022.

Thesis summary:

Telsys Ltd. controls Variscite Ltd., the global leader in niche ARM-based Systems-on-Modules (SOMs), an addressable market of $1 billion, growing by 15% annually.

Founded in 2003 and evolving methodically with a unique focus over the years, Variscite has managed to establish an wide economic moat around its business. As a highly profitable company with software-like margins (operating margin of 40-45%), Variscite has built an impressive track record of reinvestment in growth capex and R&D, which has allowed the company to grab market share steadily, growing twice as fast as the market over the past decade.

The recent valuation is reasonable, and there are growing signs that the global chip shortage has created large pent-up demand for the company’s products.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Omri Velvart is the Founder & Chief Investments Officer of Legacy Value Partners. He elevates expertise in Software and Services ecosystems, global and local Category Winners and the Digital Economy. Established in 2016, LVP explores unmatched Quality, looks for Wide Economic Moats and partners with Great Management Teams in publicly listed equities in Israel and the U.S.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Emergent Biosciences: Positive Outlook After Major Setbacks

January 9, 2022 in Audio, Best Ideas 2022, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

A.J. Noronha of Desai Capital Management presented his investment thesis on Emergent Biosciences (US: EBS) at Best Ideas 2022.

Thesis summary:

One of the last places A.J. expected to find a value opportunity is a company that had some of the most direct covid-related negative headlines of 2021. However, after further research, A.J. believes Emergent Biosciences may well be the rare exception and provide a compelling opportunity despite the large setbacks earlier in 2021.

EBS weathered the major vaccine manufacturing contamination event that became front-page news into a stronger partnership with JNJ, trades at a significant discount to intrinsic value, has both a diversified revenue-generating product line and a promising pipeline, and has strong alignment of management and shareholder incentives.

EBS appears prepared to provide vaccine solutions for either a pandemic or endemic situation over the forecast period, and also has travel health products that should benefit from a return toward normalcy.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

A.J. Noronha, CFA has over ten years of investment management experience, and has worked closely with Mr. Desai since Desai Capital Management’s inception in 2013 with all aspects of the fund, with his primary responsibilities being equity research, due diligence, and developing investment theses for DCM’s portfolio.

He has been ranked as highly as #1 (Value), #6 (Long), and #9 (both Overall and North America) in SumZero’s independent analyst rankings, and his independent research on Dow Chemical was selected as one of their top ideas of 2015.. He served as an instructor for MOI Global’s Best Ideas 2018 and Wide Moat Summit 2018, and was an invited participant (non finalist) in the 2017-2018 Sohn Conference Foundation Idea Contests, 2017 SumZero/Van Biema Value Partners Idea Challenge, and 2019 SumZero Best Short Ideas Challenge.

Prior to DCM, Mr. Noronha gained investment experience working for a mid-market PE/VC fund, and also co-founded and served in a C-level role for a biomedical engineering startup. He earned a degree in Finance, magna cum laude, from the University of Notre Dame, where he was selected to be a member of the prestigious Applied Investment Management honors finance course where students manage a portion of the University endowment under the guidance of the Chief Investment Officer, and also holds a JD with Dean’s List honors & a concentration in business enterprise (selected coursework taken through the Kellogg School of Management) from Northwestern University. He is a proud CFA Charterholder, is an active Candidate Member of the CFA Society of Chicago & serves on its Professional Development Advisory Group Board, and is a member of Irish Entrepreneurs & Harvard Alumni Entrepreneurs.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Shopify: E-Commerce Enabler Run By Exceptional Founder/CEO

January 9, 2022 in Audio, Best Ideas 2022, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Ser Jing Chong of Galilee Investment Management presented his investment thesis on Shopify (Canada/US: SHOP) at Best Ideas 2022.

Thesis summary:

Shopify is an e-commerce enabler run by co-founder and CEO Tobi Lütke, a generational business talent. Shopify thinks and acts for the long term and aims to enrich all its constituents. There is a massive market opportunity — in the form of global commerce — for the company to tackle. As a highly innovative company, plenty of new ways exist for Shopify to add value to customers and grow the business over time.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Ser Jing Chong graduated in 2012 from the National University of Singapore’s Engineering Science Programme. From January 2013 to October 2019, Ser Jing served in The Motley Fool Singapore as a writer as well as a co-leader of the investing team. One of his career highlights with Fool Singapore was to help its flagship investment newsletter, Stock Advisor Gold, outperform a global stock market benchmark by nearly 2x over a 3.5 year period. In mid-2020, he co-founded and launched Compounder Fund, a long-term focused global equities investment fund.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

The Barrier to Entry to Finding Great Investments

January 7, 2022 in Best Ideas Conference, Equities, Letters, Special Situations

This post is authored by MOI Global instructor Sam Sheldon, research analyst at Punch & Associates Investment Management, based in Saint Paul, Minnesota.

Sam is an instructor at Best Ideas 2022.

Great investors seek out businesses with strong and sustainable competitive advantages, giving these companies the opportunity for sustained success without too much competition. The challenge is that many investors are looking to own these types of businesses, and when priced for perfection, these shares may offer little value. A simple screen will uncover some of the widest-moat companies in the market: however, these often are companies with the richest valuations. Perhaps “wide moat plus easy-to-fi nd” is not the best formula for identifying opportunities across the market cap spectrum.

Beware of Buying Great Companies

To be successful for our clients, we fi nd what we believe are great businesses and hold them long enough for others to arrive at the same conclusion. We generally hold companies for three to five years. Also, to minimize risk, we should be reluctant to overpay.

Many investors construct portfolios using companies identified through quantitative screens with limited consideration of any qualitative factors. Anyone can run a screen, and this overly simplistic approach is perhaps the reason for the proliferation of the ETF. By contrast, it is more difficult to identify the companies that these screens might miss. An example of a company a screen may overlook is one that allows a mature legacy product to run off while seeding a dynamic growing business. The only way to determine whether to invest in a business or not is to develop a deeper understanding of the business and its prospects.

When we think we have found a compelling investment at a discount, we are repeatedly asking ourselves questions like, “What am I missing?” (Or, alternatively, “What am I getting away with?”) The best way to fi nd answers is to talk to management and research the company’s competitors. Many investors don’t bother to take this qualitative step, and quantitative screens only go so far. Our goal is to have other investors gravitate toward our idea overtime as our company gains recognition, because a permanently undiscovered company is of no value to our clients.

Usually, there is a clear reason for finding a company so cheaply priced. Have we considered all the reasons? How temporary or permanent are the reasons? Of course, investors will never have perfect information; part of an investor’s job is to make an assessment with imperfect information. But, to skew the odds in our favor, we look in areas where we know there are structural reasons that result in mispriced, higher-quality businesses.

Small companies and forced selling situations are fertile hunting grounds. Index kick-outs, company spin-offs, taxloss harvesting, and companies emerging from bankruptcy are also examples where owners’ reasons for selling are not tied to the underlying fundamentals of a business. Finally, companies in transition and those recovering from a failed initial public offering can present steep discounts to their intrinsic value.

Smaller Small Caps

Small cap companies – and, more specifically, the smallest small caps – can offer compelling opportunities that few investors are willing to research because of liquidity concerns and a lack of information about the company. Investors willing to do the hard work of reviewing SEC fi lings, talking to management and competitors, and methodically building a position can uncover many great businesses in this market cap range. With less capital targeting this segment of the market, stocks are less efficiently priced, and often opportunities are more plentiful. On the other hand, an investor needs to be more patient and willing to tolerate a higher level of volatility. The data below confirms our belief that smaller companies, in the aggregate, outperform over time.

Source: Kenneth French Library, value weighted returns from 1927-2020.

Kick-Outs

Every June, the Russell 2000 Index reviews its holdings and will drop or add approximately 100 to 200 stocks. Companies usually fi nd themselves on the kick-out list after, for example, a decrease in their market cap. This decrease could either be due to challenges the company is experiencing in its business or something like a stock buyback (which reduces the outstanding share count and, therefore, the market capitalization of the company) or some other shareholder-friendly action. Dropped securities come under selling pressure from passive funds and active managers who may be restricted from owning companies that are not in the index. Opportunity arises from substantial selling pressure that is not directly tied to the underlying fundamentals of these businesses (which may not be deteriorating as much as the falling share price would suggest).

Spin-Offs

A spin-off occurs when a parent company determines that a subsidiary is better off as an independent entity and distributes the business unit to current shareholders. The new company may be so small that its new shareholders might sell it indiscriminately. This selling could be due to constraints of time, capital, or the number of positions allowed in a portfolio. Portfolio managers might also sell the new shares because they do not align with the manager’s objectives. The new company might have attractive characteristics which previously went unrecognized because it was part of a larger organization. As a standalone company, the newly created entity has the freedom to focus on its core business.

Source: Bloomberg data. Cumulative returns as of December 27, 2021.

Investors end up dismissing businesses with great potential without much thought, and some businesses trade at illogical valuations temporarily. In addition, the opportunity can remain undiscovered for an extended period, as spin-off s typically don’t “screen” well. Also, the financial information for the company is not always easy to find and therefore not accurately entered into financial databases. While the effect of spin-off s is well-documented, they continue to outperform the market in general as shown above.

Tax-Loss Harvesting

A common practice among certain investors is tax-loss harvesting. This is the practice of selling a security that fell in value since the initial purchase, waiting the necessary time to avoid tripping IRS “wash sale” rules, and then repurchasing the same securities at a later date. The goal for investors is to realize the losses in a portfolio to help off set any gains. During the last few months of the calendar year this practice can accelerate, as investors naturally start to think about their tax liability. This practice meaningfully impacts small cap stock prices, and opportunities can arise from selling pressure not tied to the underlying fundamentals.

Source: Bloomberg data and Punch & Associates.

Phoenixes

Companies emerging from the ashes of bankruptcy usually have new shareholders that once were creditors. Given that many managers of credit strategies have a mandate to only hold debt in their portfolios, they have an eagerness to sell out of the equity as soon as practical. It is worth noting that some companies go into bankruptcy because of a capital structure issue and not a permanent impairment of the underlying business. Post-bankruptcy, balance sheets are usually much improved, and selling by unwilling equity holders can temporarily depress the valuation of a solid business with a much-improved capital structure. The new cost structure is usually not easily discovered by a simple screen and can take several months before the improvements are readily apparent.

Broken Deals

What behavioral finance refers to as “anchoring” also creates a pocket of investment opportunity. When a company sells shares to investors in an offering, the price at which the transaction occurs can stick in the minds of both parties. If a share price falls below the initial public offering price, post-offering it becomes known as a “broken deal.” Often, broken deals can be caused by miscommunication during the deal’s marketing process or inexperienced public executives’ faux pas on early earnings calls as a public company and not a deterioration of the business fundamentals. Rather than patiently own an immature company that may be going through some growing pains, many investors will decide that the initial buy thesis was “wrong” and arbitrarily sell the position rather than risk further losses.

Metamorphosing Enterprises

Businesses in transition may also create an investment opportunity. Many companies that have mature legacy products or services provide the cash for another part of the business that is growing. Because these mature product lines are shrinking, the company likely won’t “screen” well during the transition. Revenue growth may not reach expectations, resulting in some investment managers avoiding the company in search of faster-growing companies. Profitability may look compressed as the company is feeding its undiscovered growth engine, sometimes resulting in value managers avoiding the investment. If the pivot is a success, the tangential business can become a meaningful contributor to overall profits, and the market may eventually reward this effort. We recognize that there is a risk to investing in businesses in transition and, instead of value, we may find “value traps.” However, the only way to know if the pivot is likely to be a success is to fully understand the transition inside the company, which often requires old fashioned boots on the ground research of meeting with management teams, touring facilities and speaking with competitors. These qualitative insights cannot be found on a screen.

Conclusion

Active investing is difficult work, and there is no guarantee of success. If you screen for perfection, you may overpay for an investment, which is why investors should be suspicious of the “obvious” opportunities. Looking in underresearched or overlooked areas of the market can increase the probability of identifying a great business with a suboptimal valuation but identifying where to look is only step one of the process. Our job is to find companies where mispricing might be temporary, and we gain confidence when we fi nd companies with positive characteristics which are not currently reflected in financial databases. Most importantly, we must make a judgement call as to whether the company might someday exhibit the same characteristics as others with which we’ve enjoyed success in the past (healthier balance sheets, simplified business models, better predictability, more transparency, and, ultimately, greater recognition from a broader audience). If a company becomes better recognized by other investors, it can turn into an attractive investment for our clients.

Intelligent Investing in a World of Accelerating Growth

January 7, 2022 in Best Ideas Conference, Commentary, Letters

This post is authored by MOI Global instructor Ser Jing Chong, portfolio manager and co-founder of Compounder Fund under Galilee Investment Management, based in Singapore.

Ser Jing is an instructor at Best Ideas 2022.

The following article has been excerpted from a letter to Compounder Fund investors.

In 2016, Michael Mauboussin co-wrote a research paper entitled The Base Rate Book. Mauboussin and his co-authors studied the sales growth rates for the top 1,000 global companies by market capitalization since 1950.

They found that it was rare for a company — even for ones with a low revenue base — to produce annualized revenue growth of 20% or more for ten years. For example, of all the companies that started with revenue of less than US$325 million (adjusted for inflation to 2015-dollars), only 18.1% had a ten-year annualized revenue growth rate of more than 20%. Of all the companies that started with inflation-adjusted revenue of between US$1.25 billion and US$2.0 billion, the self-same percentage was just 3.0%.

The table below shows the percentage of companies with different starting revenues that produced annualized revenue growth in excess of 20% for ten years. You can see that no company in the dataset that started with US$50 billion in inflation-adjusted revenue achieved this level of revenue-growth.

Members, log in below to access the restricted content.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

MOI Global